Alkermes financial statements
앨커미스NASDAQ:ALKS · Nasdaq · Healthcare$41.75+2.98%
2026-10-02 closeAlkermes's published financial data is dated 2026-10-04. 2024 revenue was $1.56B. 2024 operating profit was $421M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy